Editorial Policy
This policy explains how PeptideCalculatir selects topics, checks calculations, evaluates sources, handles commercial relationships, and corrects published material.
Editorial principles
- Accuracy: formulas and unit conversions should be reproducible.
- Transparency: readers should be able to see the assumptions behind a result.
- Separation: educational arithmetic must remain separate from diagnosis, prescribing, and individualized dosing.
- Primary sourcing: regulatory and safety claims should link to official sources whenever practical.
- Proportional language: confidence in the wording should not exceed confidence in the evidence.
Topic selection
We use search-demand data to identify questions readers are asking, including reconstitution calculations, syringe-unit conversions, and named-product searches. Search volume determines what deserves a clear answer; it does not establish that a product is effective, approved, or safe.
We may decline or reframe a topic when answering it directly would require an unsupported protocol, personalized medical advice, or instructions that could facilitate unsafe use.
Calculator review
Calculator equations are written in visible form and tested with positive, zero, invalid, and unit-conversion inputs. We verify that mass units are normalized before division, that concentration is calculated before volume, and that syringe markings are tied to the selected device scale.
Mathematical testing cannot validate a visitor's label, prescription, device, product identity, sterility, or clinical decision. Interface safeguards therefore ask the visitor to confirm that inputs came from an appropriate professional or official instruction.
Sources and evidence
For regulatory status and public-safety claims, we favor agencies such as the U.S. Food and Drug Administration. For advertising-disclosure standards, we refer to Federal Trade Commission guidance. Scientific claims should be grounded in identifiable research rather than testimonials, seller copy, or social-media consensus.
Seller descriptions may be used to identify catalogue contents, formats, and listed prices. We rewrite descriptions independently and do not treat commercial product copy as proof of clinical benefit.
Medical and regulatory review
Content is structured to reduce the risk of being mistaken for medical advice. A publication date or editorial review does not mean that a physician, pharmacist, regulator, or attorney has approved every page. High-risk claims should be independently reviewed before the site leaves its current pre-launch, noindex state.
Affiliate independence
Affiliate status is disclosed near each commercial link. Editorial pages are not ranked more favorably because a product pays a higher commission. We do not publish fabricated experience, imply that we personally tested a product when we did not, or make treatment claims on behalf of a seller.
Corrections and updates
Material errors should be corrected promptly. A material correction includes a change to a formula, unit definition, approval status, safety statement, affiliate relationship, or product identity. Minor spelling and formatting changes may be made without a separate notice.
Review dates indicate when a page was last meaningfully checked; they are not a guarantee that every linked source or price remains current.
Source standards
Useful official references include the FDA overview of compounded-drug risks and the FDA safety-risk list for certain bulk substances.
PeptideCalculatir is an independent educational publishing project. Contact the editorial team at [email protected]. No clinical reviewer, legal business identity, postal address, or jurisdiction is claimed until verified details are supplied.
